Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 533

Similar articles for PubMed (Select 8489326)

1.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
2.

Improvements in depression severity in hospitalized patients with and without borderline personality features.

Yoshimatsu K, Rosen BH, Kung S, Palmer BA.

J Psychiatr Pract. 2015 May;21(3):208-13. doi: 10.1097/PRA.0000000000000068.

PMID:
25955263
3.

[The ICD-10 Symptom Rating (ISR): Validation of the Depression Scale in a Clinical Sample].

Brandt WA, Loew T, von Heymann F, Stadtmüller G, Georgi A, Tischinger M, Strom F, Mutschler F, Tritt K.

Psychother Psychosom Med Psychol. 2015 Jun;65(6):234-7. doi: 10.1055/s-0034-1398542. Epub 2015 Apr 28. German.

PMID:
25919057
4.

A case of the serotonin syndrome secondary to phenelzine monotherapy at therapeutic dosing.

Malik A, Junglee N.

Case Rep Med. 2015;2015:931963. doi: 10.1155/2015/931963. Epub 2015 Mar 16.

5.

Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer.

Shin SH, Hui D, Chisholm G, Kang JH, Allo J, Williams J, Bruera E.

Cancer Res Treat. 2014 Nov 24. doi: 10.4143/crt.2013.229. [Epub ahead of print]

6.

Nonverbal communication of patients with borderline personality disorder during clinical interviews: a double-blind placebo-controlled study using intranasal oxytocin.

Brüne M, Kolb M, Ebert A, Roser P, Edel MA.

J Nerv Ment Dis. 2015 Feb;203(2):107-11. doi: 10.1097/NMD.0000000000000240.

PMID:
25594788
7.

First evidence of a prospective relation between avoidance of internal states and borderline personality disorder features in adolescents.

Sharp C, Kalpakci A, Mellick W, Venta A, Temple JR.

Eur Child Adolesc Psychiatry. 2015 Mar;24(3):283-90. doi: 10.1007/s00787-014-0574-3. Epub 2014 Jun 24.

PMID:
24958159
8.

Naturalistic study on ICD-10 personality disorders.

Modestin J, Neuenschwander M, Rössler W.

Int J Psychiatry Clin Pract. 2006;10(4):252-7. doi: 10.1080/13651500600650067.

PMID:
24941143
9.

Quetiapine in patients with borderline personality disorder and psychosis: a case series.

Gruettert T, Friege L.

Int J Psychiatry Clin Pract. 2005;9(3):180-6. doi: 10.1080/13651500510029048.

PMID:
24937788
10.

Association between level of personality organization as assessed with theory-driven profiles of the Dutch Short Form of the MMPI and outcome of inpatient treatment for personality disorder.

Scholte WR, Eurelings-Bontekoe EH, Tiemens BG, Verheul R, Meerman A, Hutschemaekers GJ.

Bull Menninger Clin. 2014 Spring;78(2):160-76. doi: 10.1521/bumc.2014.78.2.160.

PMID:
24870848
11.

Treatment progress in medium security hospital settings for women: changes in symptoms, personality and service need from admission to discharge.

Long CG, Dolley O, Hollin CR.

Crim Behav Ment Health. 2015 Apr;25(2):99-111. doi: 10.1002/cbm.1911. Epub 2014 May 28.

PMID:
24865814
12.

Comorbid atypical depression in borderline personality disorder is common and correlated with anxiety-related psychopathology.

Gremaud-Heitz D, Riemenschneider A, Walter M, Sollberger D, Küchenhoff J, Dammann G.

Compr Psychiatry. 2014 Apr;55(3):650-6. doi: 10.1016/j.comppsych.2013.11.021. Epub 2013 Dec 7.

PMID:
24457033
13.

Covariance and specificity in adolescent schizotypal and borderline trait expression.

Badoud D, Billieux J, Eliez S, Imhof A, Heller P, Eytan A, Debbané M.

Early Interv Psychiatry. 2014 Jan 16. doi: 10.1111/eip.12120. [Epub ahead of print]

PMID:
24428891
14.

Prevalence of borderline personality disorder in immigrants in a psychiatric inpatient setting.

Nielsen F, Ziegenbein M, Sieberer M.

Aust N Z J Psychiatry. 2014 May;48(5):488. doi: 10.1177/0004867413518618. Epub 2013 Dec 23. No abstract available.

PMID:
24366855
15.

Personality dimensions and measures potentially relevant to health: A focus on hostility.

Friedman HS, Tucker JS, Reise SP.

Ann Behav Med. 1995 Sep;17(3):245-53. doi: 10.1007/BF02903919.

PMID:
24203536
16.

Efficacy of omega-3 fatty acids in the treatment of borderline personality disorder: a study of the association with valproic acid.

Bellino S, Bozzatello P, Rocca G, Bogetto F.

J Psychopharmacol. 2014 Feb;28(2):125-32. doi: 10.1177/0269881113510072. Epub 2013 Nov 5.

PMID:
24196948
17.

An exploratory study of the relationship of symptom domains and diagnostic severity to PET scan imaging in borderline personality disorder.

Charles Schulz S, Camchong J, Romine A, Schlesinger A, Kuskowski M, Pardo JV, Cullen KR, Lim KO.

Psychiatry Res. 2013 Nov 30;214(2):161-8. doi: 10.1016/j.pscychresns.2013.05.007. Epub 2013 Sep 3.

PMID:
24011393
18.

Hostility and childhood sexual abuse as predictors of suicidal behaviour in Borderline Personality Disorder.

Ferraz L, Portella MJ, Vállez M, Gutiérrez F, Martín-Blanco A, Martín-Santos R, Subirà S.

Psychiatry Res. 2013 Dec 30;210(3):980-5. doi: 10.1016/j.psychres.2013.07.004. Epub 2013 Aug 29.

PMID:
23993466
19.

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

Amminger GP, Chanen AM, Ohmann S, Klier CM, Mossaheb N, Bechdolf A, Nelson B, Thompson A, McGorry PD, Yung AR, Schäfer MR.

Can J Psychiatry. 2013 Jul;58(7):402-8.

PMID:
23870722
20.

A new time limited psychotherapy for BPD: preliminary results of a randomized and controlled trial.

Reneses B, Galián M, Serrano R, Figuera D, Fernandez Del Moral A, López-Ibor JJ, Fuentes M, Trujillo M.

Actas Esp Psiquiatr. 2013 May-Jun;41(3):139-48. Epub 2013 May 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk